Carrier molecules for use in veterinary vaccines

Autor: Andrew A. Potter, Sylvia van Drunen Littel-van den Hurk, Volker Gerdts, George Mutwiri, James C. Richards
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Veterinary medicine
immunoglobulin A
cytotoxic T lymphocyte
immunogenicity
Neisseria meningitidis
law.invention
law
vaccine
Human papillomavirus type 16
immunoglobulin M
drug carrier
poly[di(sodium carboxylatophenoxy)] polyphosphazene
atrophic rhinitis
CD8+ T lymphocyte
glycoconjugate
Vaccines
nanoparticle
starch
Actinobacillus pleuropneumoniae
Vaccination
unclassified drug
Infectious Diseases
Streptococcus pneumoniae
virus like agent
liposome
Vaccines
Subunit

Recombinant DNA
Molecular Medicine
cytokine production
gamma interferon
DNA vaccine
glycoconjugate vaccine
dendritic cell
polymer
review
interleukin 6
Biology
interleukin 2
Bordetella bronchiseptica
immunization
immunoglobulin G2
immunoglobulin G1
Immune system
Antigen
peptide vaccine
Animals
Haemophilus vaccine
Vaccines
Virus-Like Particle

alginic acid
polyglactin
Pasteurella multocida infection
Vaccines
Conjugate

General Veterinary
General Immunology and Microbiology
poly[di(sodium carboxylatoethylphenoxy] phosphazene
business.industry
cost effectiveness analysis
bacterial load
Public Health
Environmental and Occupational Health

Haemophilus influenzae type b
immunostimulating agent
bronchopneumonia
Biotechnology
polysaccharide vaccine
CpG oligodeoxynucleotide
hepatitis B surface antigen
Infectious disease (medical specialty)
antigen presenting cell
mucosal immunity
Nanoparticles
chitosan
influenza vaccine
business
Wart virus vaccine
Glycoconjugates
Popis: The practice of immunization of animals and humans has been carried out for centuries and is generally accepted as the most cost effective and sustainable method of infectious disease control. Over the past 20 years there have been significant changes in our ability to produce antigens by conventional extraction and purification, recombinant DNA and synthesis. However, many of these products need to be combined with carrier molecules to generate optimal immune responses. This review covers selected topics in the development of carrier technologies for use in the veterinary vaccine field, including glycoconjugate and peptide vaccines, microparticle and nanoparticle formulations, and finally virus-like particles. © 2012.
Databáze: OpenAIRE